Analysts Still Jumping on Human Genome Sciences (HGSI) Bandwagon: 3 Upgrades Today

Following yesterday's nearly 300% jump on news that a trial of BENLYSTA met its primary endpoint, analysts are continuing to jump on the Human Genome Sciences (Nasdaq: HGSI) bandwagon today.

Today:

• upgraded from Market Perform to Outperform at Bernstein
  
• upgraded from Neutral to Buy at UBS
  
• upgraded from Source of Funds to Accumulate at ThinkEquity

Yesterday:

• upgraded from Hold to Buy at Citi
  
• upgraded from Sell to Hold at Lazard
  
• upgraded from Neutral to Overweight at Piper Jaffray

To see all these calls in a clickable list format, visit our Analyst Ratings page.

You May Also Be Interested In

• Citi upgrades O-I Glass to Buy with $9 price target, opens 90-Day upside catalyst watch
• Wells Fargo Upgrades Portland General Electric Company (POR) to Overweight
• Andersen closes secondary offering of 4.9M shares at $44 each